Evaluation of drug-drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjects.
Chen J, Wu J, Guo N, Song Y, Li L, Wang B, Li J, Hou M, Yin H, Zhang M, Kong Y, Wu X, Li R, Wu L, Gao Q, Dong R.
Chen J, et al. Among authors: wu x.
Clin Transl Sci. 2024 Nov;17(11):e70063. doi: 10.1111/cts.70063.
Clin Transl Sci. 2024.
PMID: 39533673
Clinical Trial.